1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate
C21H30N2O7 — CID 102300190
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate
1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate (PubChem CID 102300190) has the molecular formula C21H30N2O7 and a molecular weight of 422.48 g/mol. Its IUPAC name is 1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate.
Molecular Properties
| Compound Name | 1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate |
|---|---|
| PubChem CID | 102300190 |
| Molecular Formula | C21H30N2O7 |
| Molecular Weight | 422.48 g/mol |
| Exact Mass | 422.21 |
| IUPAC Name | 1-O-tert-butyl 6-O-methyl 4-[2-(3,4-dimethoxyphenyl)ethyl]-3-hydroxy-2,3-dihydropyrazine-1,6-dicarboxylate |
| SMILES | COC(=O)C1=CN(CCc2ccc(OC)c(OC)c2)C(O)CN1C(=O)OC(C)(C)C |
| InChI | InChI=1S/C21H30N2O7/c1-21(2,3)30-20(26)23-13-18(24)22(12-15(23)19(25)29-6)10-9-14-7-8-16(27-4)17(11-14)28-5/h7-8,11-12,18,24H,9-10,13H2,1-6H3 |
| InChIKey | TTWUAWKFQWDZRF-UHFFFAOYSA-N |
| XLogP | 2.13 |
| TPSA | 97.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.48 |
| LogP ≤ 5 | 2.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 102300190 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.